BioSpace News Archive

NRGene Technology Efficiently Analyzes Abnormalities in Multiple Human Genomes

NRGene has demonstrated its ability to discover, analyze, and track abnormalities within the human genome, across multiple subjects.

October 17, 2017

·

2 min read

Deals

Neothetics and Evofem Biosciences Announce Merger Agreement to Create Women’s Health Company

The merger will position the combined company with an opportunity to become a leading women’s health company that develops and commercializes novel products.

October 17, 2017

·

12 min read

PositiveID’s E-N-G Mobile Systems’ Announces Incorporation of Advanced Drone Technology

ENG’s new drone initiative to enable real-time communication in challenging environments and help deliver market edge

October 17, 2017

·

5 min read

Business

Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call

The financial results will be released after market close on Monday, October 30, 2017.

October 17, 2017

·

1 min read

Bio NC

CEM Introduces the Future of Molecular Sample Preparation

CEM is pleased to introduce the all new EDGE extraction system for rapid sample preparation of GC/LC samples.

October 17, 2017

·

2 min read

Business

Askbio and Columbus Venture Partners Launch Gene Therapy Company Viralgen

Asklepios BioPharma announced the formation of Viralgen, a gene therapy joint venture with Columbus Venture Partners.

October 17, 2017

·

3 min read

Drug Development

Aduro Biotech Announces Presentation of Phase I Data for LADD-based Immunotherapy at World Conference on Lung Cancer

The Phase 1 first-in-human, open label dose-finding trial included nine patients with advanced stage relapsed or refractory non-small cell lung cancer.

October 17, 2017

·

5 min read

Drug Development

Cellectar Biosciences Receives Additional Japanese Patent for CLR 131 and CLR 125 for the Treatment of Various Solid Tumors

The Japanese Patent Office has granted it a patent covering both composition of matter and method of use for CLR 131 and CLR 125.

October 17, 2017

·

6 min read

Drug Development

Xenon Pharmaceuticals Announces Initiation of XEN1101 Phase I Clinical Trial

Xenon’s innovative, proprietary epilepsy programs continue to advance in development.

October 17, 2017

·

8 min read

Pharm Country

Celsion Provides Summary of Research and Development Day Held on Thursday, October 12, 2017

The presentations focused on the Company’s research and development program using ThermoDox for the treatment of primary liver cancer, also known as hepatocellular carcinoma or HCC.

October 17, 2017

·

6 min read